ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

New Mammography Guidelines Cut Uses By Women Under 50 t 25%

July 29, 1977

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

June 1, 2007